
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (35): 5259-5265.DOI: 10.12114/j.issn.1007-9572.2024.0393
• Article • Previous Articles Next Articles
Received:2024-07-18
Revised:2025-09-06
Published:2026-12-15
Online:2026-10-26
Contact:
XIONG Ying
通讯作者:
熊英
作者简介:作者贡献:
熊英提出主要研究目标,负责研究的构思与设计,论文的修订,对文章整体负责,监督管理。朱延负责研究的实施,撰写论文,数据的收集与整理,统计学处理,图、表的绘制与展示。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0393
| 组别 | 只数 | 3.125 g/L | 6.250 g/L | 12.500 g/L | 25.000 g/L | 50.000 g/L |
|---|---|---|---|---|---|---|
| 对照组 | 6 | 1.11±0.18 | 2.81±0.58 | 4.88±0.36 | 4.91±0.94 | 5.11±0.27 |
| 哮喘模型组 | 7 | 1.54±0.70 | 2.64±0.35 | 4.66±0.73 | 7.46±0.70a | 8.24±0.57a |
| 捏脊干预组 | 7 | 1.34±0.73 | 2.82±0.56 | 4.81±0.73 | 4.14±0.84b | 5.07±0.37b |
| 甲基泼尼松龙组 | 7 | 1.02±0.16 | 2.62±0.46 | 4.63±0.14 | 4.26±0.16b | 5.15±0.46b |
| F值 | 1.35 | 0.32 | 0.30 | 32.83 | 88.48 | |
| P值 | >0.05 | >0.05 | >0.05 | <0.05 | <0.05 |
Table 1 Comparison of Penh values of rats in each group at different concentrations of Ach excitation
| 组别 | 只数 | 3.125 g/L | 6.250 g/L | 12.500 g/L | 25.000 g/L | 50.000 g/L |
|---|---|---|---|---|---|---|
| 对照组 | 6 | 1.11±0.18 | 2.81±0.58 | 4.88±0.36 | 4.91±0.94 | 5.11±0.27 |
| 哮喘模型组 | 7 | 1.54±0.70 | 2.64±0.35 | 4.66±0.73 | 7.46±0.70a | 8.24±0.57a |
| 捏脊干预组 | 7 | 1.34±0.73 | 2.82±0.56 | 4.81±0.73 | 4.14±0.84b | 5.07±0.37b |
| 甲基泼尼松龙组 | 7 | 1.02±0.16 | 2.62±0.46 | 4.63±0.14 | 4.26±0.16b | 5.15±0.46b |
| F值 | 1.35 | 0.32 | 0.30 | 32.83 | 88.48 | |
| P值 | >0.05 | >0.05 | >0.05 | <0.05 | <0.05 |
| 组别 | 只数 | 气道炎症评分 |
|---|---|---|
| 对照组 | 6 | 0.75±0.20 |
| 哮喘模型组 | 7 | 2.25±0.45a |
| 捏脊干预组 | 7 | 1.75±0.32ab |
| 甲基泼尼松龙组 | 7 | 1.60±0.52ab |
| F值 | 15.57 | |
| P值 | <0.05 |
Table 2 Comparison of airway inflammation scores in lung tissues among each group of rats
| 组别 | 只数 | 气道炎症评分 |
|---|---|---|
| 对照组 | 6 | 0.75±0.20 |
| 哮喘模型组 | 7 | 2.25±0.45a |
| 捏脊干预组 | 7 | 1.75±0.32ab |
| 甲基泼尼松龙组 | 7 | 1.60±0.52ab |
| F值 | 15.57 | |
| P值 | <0.05 |
| 组别 | 只数 | IgE(mg/L) | IFN-γ(ng/L) | IL-4(ng/L) | TNF-α(ng/L) |
|---|---|---|---|---|---|
| 对照组 | 6 | 15.81±2.18 | 1 437.12±156.84 | 57.71±5.24 | 181.35±24.77 |
| 哮喘模型组 | 7 | 21.14±2.70a | 1 203.34±157.29 | 80.95±8.79a | 257.37±29.83a |
| 捏脊干预组 | 7 | 18.84±2.73ab | 1 326.80±176.46 | 68.81±9.19ab | 221.83±27.49ab |
| 甲基泼尼松龙组 | 7 | 20.02±2.16a | 1 281.35±155.57 | 71.56±9.01ab | 215.01±21.61ab |
| F值 | 5.50 | 2.36 | 8.52 | 9.25 | |
| P值 | <0.05 | >0.05 | <0.05 | <0.05 |
Table 3 Comparison of plasma IgE levels and IFN-γ, IL-4, TNF-α levels in BALF among each group of rats
| 组别 | 只数 | IgE(mg/L) | IFN-γ(ng/L) | IL-4(ng/L) | TNF-α(ng/L) |
|---|---|---|---|---|---|
| 对照组 | 6 | 15.81±2.18 | 1 437.12±156.84 | 57.71±5.24 | 181.35±24.77 |
| 哮喘模型组 | 7 | 21.14±2.70a | 1 203.34±157.29 | 80.95±8.79a | 257.37±29.83a |
| 捏脊干预组 | 7 | 18.84±2.73ab | 1 326.80±176.46 | 68.81±9.19ab | 221.83±27.49ab |
| 甲基泼尼松龙组 | 7 | 20.02±2.16a | 1 281.35±155.57 | 71.56±9.01ab | 215.01±21.61ab |
| F值 | 5.50 | 2.36 | 8.52 | 9.25 | |
| P值 | <0.05 | >0.05 | <0.05 | <0.05 |
| 组别 | 只数 | 定位航行潜伏期(s) | 穿越平台次数(次) | |||
|---|---|---|---|---|---|---|
| 第1天 | 第2天 | 第3天 | 第4天 | |||
| 对照组 | 6 | 73.5±7.5 | 47.4±5.3 | 42.3±5.5 | 35.8±8.3 | 6.1±2.3 |
| 哮喘模型组 | 7 | 66.4±4.7a | 45.3±5.7 | 38.4±6.5 | 45.4±8.7a | 4.4±3.3 |
| 捏脊干预组 | 7 | 51.2±6.3ab | 43.8±5.3 | 37.2±6.7 | 21.8±7.3ab | 7.8±2.4 |
| 甲基泼尼松龙组 | 7 | 58.3±5.1abc | 44.1±6.1 | 45.3±5.7 | 40.1±8.1c | 6.1±2.1 |
| F值 | 17.47 | 0.54 | 3.95 | 10.88 | 2.02 | |
| P值 | <0.05 | >0.05 | >0.05 | <0.05 | >0.05 | |
Table 4 Comparison of learning and memory performance among each group of rats
| 组别 | 只数 | 定位航行潜伏期(s) | 穿越平台次数(次) | |||
|---|---|---|---|---|---|---|
| 第1天 | 第2天 | 第3天 | 第4天 | |||
| 对照组 | 6 | 73.5±7.5 | 47.4±5.3 | 42.3±5.5 | 35.8±8.3 | 6.1±2.3 |
| 哮喘模型组 | 7 | 66.4±4.7a | 45.3±5.7 | 38.4±6.5 | 45.4±8.7a | 4.4±3.3 |
| 捏脊干预组 | 7 | 51.2±6.3ab | 43.8±5.3 | 37.2±6.7 | 21.8±7.3ab | 7.8±2.4 |
| 甲基泼尼松龙组 | 7 | 58.3±5.1abc | 44.1±6.1 | 45.3±5.7 | 40.1±8.1c | 6.1±2.1 |
| F值 | 17.47 | 0.54 | 3.95 | 10.88 | 2.02 | |
| P值 | <0.05 | >0.05 | >0.05 | <0.05 | >0.05 | |
| 组别 | 只数 | CA1区 | DG区 |
|---|---|---|---|
| 对照组 | 6 | 0.40±0.01 | 0.41±0.01 |
| 哮喘模型组 | 7 | 0.32±0.01a | 0.36±0.01a |
| 捏脊干预组 | 7 | 0.41±0.02b | 0.42±0.02b |
| 甲基泼尼松龙组 | 7 | 0.38±0.01b | 0.38±0.01 |
| F值 | 73.85 | 34.23 | |
| P值 | <0.05 | <0.05 |
Table 5 Comparison of BDNF levels in hippocampal tissue of rats
| 组别 | 只数 | CA1区 | DG区 |
|---|---|---|---|
| 对照组 | 6 | 0.40±0.01 | 0.41±0.01 |
| 哮喘模型组 | 7 | 0.32±0.01a | 0.36±0.01a |
| 捏脊干预组 | 7 | 0.41±0.02b | 0.42±0.02b |
| 甲基泼尼松龙组 | 7 | 0.38±0.01b | 0.38±0.01 |
| F值 | 73.85 | 34.23 | |
| P值 | <0.05 | <0.05 |
| [1] | |
| [2] |
任蒙丽. 过敏性哮喘模型小鼠认知功能的改变及其机制研究[D]. 重庆: 重庆医科大学, 2021.
|
| [3] |
|
| [4] |
|
| [5] |
樊璞.基于海马-HPA轴探讨捏脊法预防CUMS致青少年期鼠抑郁的效应机制研究[D].南京: 南京中医药大学, 2022.
|
| [6] |
熊英,沈楚楚,樊璞,等. 捏脊法对脾虚哮喘大鼠肠道菌群和肺部炎症的影响[J]. 中医杂志, 2018, 59(1): 61-65. DOI: 10.13288/j.11-2166/r.2018.01.015.
|
| [7] |
钱星羽. 捏脊疗法干预幼龄厌食大鼠及调控下丘脑摄食中枢的效应与机制研究[D]. 天津: 天津中医药大学, 2023.
|
| [8] |
龚梦华,吴倩雯,李一纯,等. 捏脊疗法对自闭症模型大鼠焦虑样行为及NF-κB通路的影响[J]. 云南中医中药杂志, 2023, 44(4): 81-85. DOI: 10.16254/j.cnki.53-1120/r.2023.04.006.
|
| [9] | |
| [10] |
|
| [11] |
|
| [12] |
杨瑾禹,丁圣刚,张素丽,等. 标准化变应原皮下特异性免疫治疗对单一与多重过敏性哮喘儿童的疗效对比[J]. 安徽医科大学学报, 2023, 58(7): 1200-1204. DOI: 10.19405/j.cnki.issn1000-1492.2023.07.023.
|
| [13] |
|
| [14] |
廖成松,韩阳阳,陈志婧. 黑种草保健茶水浸液对OVA诱导小鼠过敏性哮喘的作用[J]. 中成药, 2021, 43(9): 2514-2519. DOI: 10.3969/j.issn.1001-1528.2021.09.046.
|
| [15] |
唐徐韵,陈盼碧,杜狄佳,等. 基于p38 MAPK信号通路探讨穴位埋线对哮喘大鼠肺组织Th1/Th2失衡及EOS的影响[J]. 中国中医基础医学杂志, 2023, 29(1): 86-90. DOI: 10.19945/j.cnki.issn.1006-3250.2023.01.017.
|
| [16] |
吴星,刘爽,周长江,等. 槐杞黄颗粒联合异丙托溴铵吸入气雾剂对哮喘患者的临床疗效[J]. 中成药, 2022, 44(2): 422-427. DOI: 10.3969/j.issn.1001-1528.2022.02.015.
|
| [17] |
张丽娟,任苓苓,王令敏,等. 宣肺解痉方治疗支气管哮喘的临床疗效及对血清TGF-β1、MMP-9、TNF-α水平的影响[J]. 辽宁中医杂志, 2022, 49(4): 50-54. DOI: 10.13192/j.issn.1000-1719.2022.04.015.
|
| [18] | |
| [19] | |
| [20] |
刘昱含,张艺馨,宋一讷,等. 基于血脑屏障完整性探讨神经源性炎症疾病中星形胶质细胞与T细胞互作[J]. 中国免疫学杂志, 2025, 41(10): 2521-2529.
|
| [21] |
王芳,王丽春,韩彩玲,等. 血管内皮生长因子调节蛋白激酶C表达对子宫内膜异位症间质细胞侵袭性的影响[J]. 宁夏医科大学学报, 2024, 46(8): 757-764. DOI: 10.16050/j.cnki.issn1674-6309.2024.08.001.
|
| [22] |
|
| [23] |
|
| [24] |
高守连,国生,李莹君,等. 振腹推拿手法对抽动障碍模型大鼠纹状体及皮质区神经营养因子水平的影响[J]. 环球中医药, 2024(11): 2170-2175.
|
| [25] |
曹若菡,李珊珊,郭耀东. 捏脊疗法联合穴位点按对小儿功能性消化不良的护理干预研究[J]. 商洛学院学报, 2024, 38(4): 76-80, 96. DOI: 10.13440/j.slxy.1674-0033.2024.04.012.
|
| [1] | XIONG Xiaoman, LI Aijun, ZHENG Yuehong, YANG Qiuyan, ZHANG Yanli. To Explore the Necessity of Bronchodilation Test in Children with Normal FEV1, FVC and FEV1/FVC but Decreased Small Airway Function [J]. Chinese General Practice, 2026, 29(15): 1992-1997. |
| [2] | ZHAO Xuedan, AI Yue, JIN Guoen, JIA Guoqiang. The New Research Progress of Non-infectious Lung Diseases in High Altitude Areas [J]. Chinese General Practice, 2026, 29(14): 1931-1938. |
| [3] | WANG Gaoming, WANG Minghang, YANG Jiang, MENG Yuanyuan, ZHAO Di, DONG Xiaosheng. Systematic Evaluation and Reflection on the Quality of Bronchial Asthma Guidelines in China [J]. Chinese General Practice, 2026, 29(10): 1239-1245. |
| [4] | WU Zhongping, ZHENG Jingping, GAO Yi, CHEN Xiaoliang. Investigation and Analysis of the Current Status of Bronchial Provocation Testing in Guangdong Province [J]. Chinese General Practice, 2025, 28(33): 4166-4171. |
| [5] | NA Feiyang, ZHANG Rongfang, ZHAO Qijun, LIANG Xuan, WANG Yong, WANG Yannan. Study on the Control Rate and Influencing Factors of Bronchial Asthma in School-aged Children [J]. Chinese General Practice, 2025, 28(33): 4187-4191. |
| [6] | NA Feiyang, YANG Yi, WANG Yong, WANG Yannan. Study on the Etiology of Chronic Cough in Children Aged 0-14 Years in Lanzhou from 2014 to 2023 [J]. Chinese General Practice, 2025, 28(24): 3026-3031. |
| [7] | TAN Huihui, MAO Wei, YANG Zihan. Research Progress of Annexin A1 in Respiratory Diseases [J]. Chinese General Practice, 2025, 28(13): 1668-1673. |
| [8] | GUO Xin, ZHOU Mingjuan, FAN Feiting, XIAO Jingmin, CHI Yihe, WU Lei, LIN Lin, CHEN Yuanbin. Acupoint Application with Tianjiu Powder for Pre-asthma: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(11): 1367-1375. |
| [9] | ZHU Yaming, DU Li, WANG Huanhui, WANG Peipei. Obstructive Sleep Apnea-hypopnea Syndrome and Severe Asthma: Advances and Challenges [J]. Chinese General Practice, 2024, 27(25): 3192-3196. |
| [10] | YANG Qiao, LIU Yulin, WANG Chongjie, LIU Enmei, FU Zhou, CHEN Fei. Evaluation Study of Childhood Bronchial Asthma Prevention and Treatment Services by Primary Care General Practitioners in Chongqing [J]. Chinese General Practice, 2024, 27(22): 2780-2788. |
| [11] | QU Yuanyuan, CAO Miao, WANG Jing, CHENG Li, HE Xiaoshuang. Trends in Prevalence and Burden of Asthma and Its Risk Factors in China, 1990-2019 [J]. Chinese General Practice, 2024, 27(13): 1594-1600. |
| [12] | GAO Sijie, CHEN Zelin, WU Siyu, WANG Zheng, MENG Aihong. Clinical Characteristics of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Asthma-chronic Obstructive Pulmonary Disease Overlap Patients with Different Low Attenuation Area Grades [J]. Chinese General Practice, 2024, 27(12): 1468-1474. |
| [13] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
| [14] | LI Jingbo, PANG Gaofeng, REN Yanling, SHA Xixue, NI Huiping. Executive Function of GO/NOGO Paradigm Experiment in Children with Bronchial Asthma and Its Relationship with Pulmonary Function [J]. Chinese General Practice, 2023, 26(20): 2503-2507. |
| [15] | DU Yeming, ZHANG Yunqiao, WANG Zongqi, MIN Xue, CUI Yalian, WANG Yanfang. Characteristics of Somatic Symptoms and Their Correlations with Brain-derived Neurotrophic Factor and Inflammatory Cytokinesin Patients with Major Depressive Disorder [J]. Chinese General Practice, 2023, 26(12): 1463-1471. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||